158 related articles for article (PubMed ID: 32506835)
1. Staphylococcus aureus biofilm exoproteins are cytotoxic to human nasal epithelial barrier in chronic rhinosinusitis.
Panchatcharam BS; Cooksley CM; Ramezanpour M; Vediappan RS; Bassiouni A; Wormald PJ; Psaltis AJ; Vreugde S
Int Forum Allergy Rhinol; 2020 Jul; 10(7):871-883. PubMed ID: 32506835
[TBL] [Abstract][Full Text] [Related]
2. Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.
Tuli JF; Ramezanpour M; Cooksley C; Psaltis AJ; Wormald PJ; Vreugde S
Allergy; 2021 Nov; 76(11):3459-3469. PubMed ID: 34033126
[TBL] [Abstract][Full Text] [Related]
3. S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis.
Shaghayegh G; Cooksley C; Bouras G; Panchatcharam BS; Feizi S; Javadian S; Ramezanpour M; Fenix KA; Wormald PJ; Psaltis AJ; Vreugde S
Clin Immunol; 2024 Jun; 263():110221. PubMed ID: 38636891
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus impairs the airway epithelial barrier in vitro.
Malik Z; Roscioli E; Murphy J; Ou J; Bassiouni A; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2015 Jun; 5(6):551-6. PubMed ID: 25821008
[TBL] [Abstract][Full Text] [Related]
5. In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus.
Murphy J; Ramezanpour M; Drilling A; Roscioli E; Psaltis AJ; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2019 Feb; 9(2):187-196. PubMed ID: 30431711
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
[TBL] [Abstract][Full Text] [Related]
7. Sub-Inhibitory Clindamycin and Azithromycin reduce
Hu H; Ramezanpour M; Hayes AJ; Liu S; Psaltis AJ; Wormald PJ; Vreugde S
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31590226
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro.
Murphy J; Ramezanpour M; Stach N; Dubin G; Psaltis AJ; Wormald PJ; Vreugde S
Laryngoscope; 2018 Jan; 128(1):E8-E15. PubMed ID: 28994126
[TBL] [Abstract][Full Text] [Related]
9. S. aureus biofilm metabolic activity correlates positively with patients' eosinophil frequencies and disease severity in chronic rhinosinusitis.
Shaghayegh G; Cooksley C; Bouras G; Houtak G; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
Microbes Infect; 2023; 25(8):105213. PubMed ID: 37652259
[TBL] [Abstract][Full Text] [Related]
10. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.
Soyka MB; Wawrzyniak P; Eiwegger T; Holzmann D; Treis A; Wanke K; Kast JI; Akdis CA
J Allergy Clin Immunol; 2012 Nov; 130(5):1087-1096.e10. PubMed ID: 22840853
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
12.
Li J; Ramezanpour M; Fong SA; Cooksley C; Murphy J; Suzuki M; Psaltis AJ; Wormald PJ; Vreugde S
Front Cell Infect Microbiol; 2019; 9():38. PubMed ID: 30873390
[No Abstract] [Full Text] [Related]
13. The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and Staphylococcus aureus in chronic rhinosinusitis.
Chegini Z; Noei M; Hemmati J; Arabestani MR; Shariati A
Cell Commun Signal; 2023 Oct; 21(1):306. PubMed ID: 37904180
[TBL] [Abstract][Full Text] [Related]
14.
Houtak G; Nepal R; Bouras G; Shaghayegh G; Bennett C; Finnie J; Fenix K; Psaltis AJ; Wormald PJ; Vreugde S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542379
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
Drilling A; Morales S; Jardeleza C; Vreugde S; Speck P; Wormald PJ
Am J Rhinol Allergy; 2014; 28(1):3-11. PubMed ID: 24717868
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiological role of bacterial biofilms in chronic sinusitis.
Dlugaszewska J; Leszczynska M; Lenkowski M; Tatarska A; Pastusiak T; Szyfter W
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):1989-94. PubMed ID: 26024693
[TBL] [Abstract][Full Text] [Related]
17. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence.
Tan NC; Foreman A; Jardeleza C; Douglas R; Tran H; Wormald PJ
Laryngoscope; 2012 Aug; 122(8):1655-60. PubMed ID: 22549739
[TBL] [Abstract][Full Text] [Related]
18. Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis.
Łusiak-Szelachowska M; Weber-Dąbrowska B; Żaczek M; Górski A
Acta Virol; 2021; 65(2):127-140. PubMed ID: 34130464
[TBL] [Abstract][Full Text] [Related]
19. A human nasal explant model to study Staphylococcus aureus biofilm in vitro.
Cantero D; Cooksley C; Jardeleza C; Bassiouni A; Jones D; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2013 Jul; 3(7):556-62. PubMed ID: 23404931
[TBL] [Abstract][Full Text] [Related]
20.
Huang S; Hon K; Bennett C; Hu H; Menberu M; Wormald PJ; Zhao Y; Vreugde S; Liu S
Front Microbiol; 2022; 13():984741. PubMed ID: 36187946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
